SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
Recruiting · NCT07523542 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-13 | NCT07523542 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Biotech | 32 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University Shenzhen Hospital | Shenzhen | China | 68 |